HomeAnti-neonatal myosin monoclonal antibody
2022

Related news
News Releases 1 February 2023

LifeArc Ventures – strong performance in 2022 & sustained investment in innovation

Highlights DJS Antibodies – portfolio company acquired by AbbVie for approx. $255 million in cash at closing…
News Releases 24 January 2023

£1 million awarded to develop cutting-edge therapies for motor neuron disease

LifeArc, Motor Neurone Disease Association and My Name’5 Doddie Foundation jointly award £1 million to progress development…
News Releases 10 January 2023

LifeArc portfolio company RQ Bio’s antibody enters clinical trials

LifeArc Ventures’ portfolio company RQ Biotechnology has announced that the first of its discovered monoclonal antibodies to…

My Interest
Academic Scientist
Pharma/Biotech
Medical Charity
MRC Scientist
Research Organisation